First Foundation Advisors Guardant Health, Inc. Transaction History

First Foundation Advisors

  • $2.58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$21.58 - $29.5 $145,708 - $199,184
-6,752 Reduced 85.76%
1,121 $30,000
Q3 2023

Nov 15, 2023
BUY
$25.8 - $39.97 $203,123 - $314,683
7,873 New
7,873 $233,000
Q1 2021

May 18, 2021
SELL
$127.04 - $179.1 $206,567 - $291,216
-1,626 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$99.96 - $135.93 $162,534 - $221,022
1,626 New
1,626 $210,000

Others Institutions Holding GH

# of Institutions
323
Shares Held
127M
Call Options Held
844K
Put Options Held
2.38M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track First Foundation Advisors Portfolio

Follow First Foundation Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email